Medical/Pharmaceuticals APAC News & Press Release Distribution

Medical/Pharmaceuticals

All
Global

AFT Launches NZ-Made, 100% Natural, 90% Recyclable Hemptuary® Skincare Range

SYDNEY, Oct. 18, 2021 /PRNewswire/ -- Skincare mavens and beauty gurus have a new product to not only feel good in but feel good about – AFT Pharmaceuticals' new skincare range, Hemptuary®, is made inNew Zealand from 100% natural ingredients and has packaging that is 90% recyclable.

2021-10-18 05:00 1563

AFT Launches NZ-Made, 100% Natural, 90% Recyclable Hemptuary® Skincare Range

Webinar on Healthcare Innovations for Sustainable Future by Kalkine Media on October 21, 2021

SYDNEY, Oct. 16, 2021 /PRNewswire/ -- Ensuring healthy lives and promoting physical and mental well-being is essential to sustainable development. Currently, the world is facing a global health crisis unlike any other. Global health has increasingly gained international visibility and prominence...

2021-10-16 06:00 3180

Novavax to Participate in World Vaccine Congress Europe

GAITHERSBURG, Md., Oct. 16, 2021 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, today announced that Vivek Shinde, M.D., Vice President, Clinical Development, will deliver a...

2021-10-16 04:39 3925

Phase II Data Of Medigen COVID-19 Vaccine, Reviewed And Published In The Lancet Respiratory Medicine

TAIPEI, Oct. 15, 2021 /PRNewswire/ -- The Lancet Respiratory Medicine , one of the world's best-known peer-reviewed medical journals has published Medigen Vaccine Biologics (...

2021-10-15 18:36 2379

Antengene to Present Data of Its PD-L1/4-1BB Bispecific Antibody ATG-101 and ERK1/2 Inhibitor ATG-017 at SITC 2021

SHANGHAI and HONG KONG, Oct. 15, 2021 /PRNewswire/ -- The 36th Annual Meeting of the Society for Immunotherapy for Cancer (SITC 2021) will take place in Washington, D.C., United States, on November 10-14, 2021. The SITC's annual meeting is the world's largest gathering in the field of immuno-oncol...

2021-10-15 13:33 2044

International Biopharma Industry Week Shanghai 2021 Opens

SHANGHAI, Oct. 15, 2021 /PRNewswire/ -- On October 11, the International Biopharma Industry Week Shanghai 2021, under the guidance of the Shanghai Biomedical Industry Development Leading Group, the inaugural International Biopharma Industry Week Shanghai (IBIWS) is co-hosted by Shanghai Biomedica...

2021-10-15 12:22 2312

International Biopharma Industry Week Shanghai 2021 Opens

Qiming's Portfolio Company Abbisko Lists on Main Board of HKEx

SHANGHAI, Oct. 15, 2021 /PRNewswire/ -- Qiming Venture Partners' portfolio company Abbisko (SEHK:2256), a clinical-stage biopharmaceutical company, listed on the main board of the Hong Kong Stock Exchange onOctober 13. The issue price isHK$ 12.46 per share, representing a market cap of HK$ 8.753 ...

2021-10-15 12:00 3181

Interim Results Of A Pioneering Combination Study In Argentina With More Than 1,000 Participants Confirm The One-shot Sputnik Light Vaccine (The First Component Of The Sputnik V Vaccine) Is An Effective Universal Booster For Vaccines Produced By AstraZeneca, Sinopharm, Moderna And Cansino Inducing Strong Immune Response And Showing High Safety Profile. Combination Of AstraZeneca And Sputnik Light Vaccines Showed High Immunogenicity Results.

* One-shot Sputnik Light is the first component of the Sputnik V vaccine, the world's first registered vaccine against coronavirus. Sputnik V pioneered the heterogeneous boosting approach (a "vaccine cocktail" using human adenovirus serotype 26 as the first component and human adenovirus seroty...

2021-10-15 05:26 2157

Gan & Lee Pharmaceuticals Concludes Phase 3 Studies of Gan & Lee Insulin Glargine (GL-GLA)

BEIJING and BRIDGEWATER, N.J., Oct. 14, 2021 /PRNewswire/ -- Gan & Lee Pharmaceuticals Co., Ltd. (hereinafter referred to as Gan & Lee) (Shanghai: 603087.SH), is pleased to announce the completion of two randomized, multicenter, phase 3 studies that compare proposed biosimilar Gan & Lee insulin ...

2021-10-14 20:46 2442

Evaxion Biotech Lauded by Frost & Sullivan for Helping Develop Highly Targeted Therapies with Its AI Immunology Platforms

The company's PIONEER™, EDEN™, and RAVEN™ platforms mimic the human immune system to simplify the drug development process for a range of diseases LONDON, Oct. 14, 2021 /PRNewswire/ -- Based on its recent analysis of the European AI-enabled drug discovery market,Frost & Sullivan recognizes Evaxio...

2021-10-14 19:30 1299

Evaxion Biotech Lauded by Frost & Sullivan for Helping Develop Highly Targeted Therapies with Its AI Immunology Platforms

BioAgilytix Closes Acquisition of Australia-based 360biolabs®

Following final government approval, 360biolabs, a BioAgilytix company, adds world-class virology & immunology expertise and LC/MS/MS small molecule capabilities to the company, enabling support of bioanalytical services across all geographies and development stages DURHAM, N.C., Oct. 14, 2021 /...

2021-10-14 19:00 1378

21 Swiss Startups to take the Stage at China's Hottest Tech Expos

SHANGHAI, Oct. 14, 2021 /PRNewswire/ -- 21 Swiss startups will be joining the primely-located SwissTech Pavilions at China Hi-Tech Fair fromNovember 17 - 21, 2021 in Shenzhen, and Tech G Shanghai International Consumer Electronics Show fromJanuary 13 - 15, 2022 in Shanghai. The world-class Swiss...

2021-10-14 16:18 677

21 Swiss Startups to take the Stage at China's Hottest Tech Expos

A China-developed COVID-19 vaccine is conducting clinical trial in Philippines

CHENGDU, China, Oct. 14, 2021 /PRNewswire/ -- Philippines is currently conducting, along with other countries includingIndonesia, Kenya, and Mexico, a Phase III clinical trial of Recombinant COVID-19 Vaccine (Sf9 cells) produced by WestVac Biopharma Co., LTD and National Key Laboratory of Bioth...

2021-10-14 12:58 1751

Restart-A-Heart Day - Targets Aussie Women

MELBOURNE, Australia, Oct. 14, 2021 /PRNewswire/ -- Recent studies reveal women are 27% less likely to receive CPR in a public setting compared to men. This has resulted in women dying unnecessarily while waiting for an ambulance as ...

2021-10-14 09:15 1754

Restart-A-Heart Day - Targets Aussie Women

New Information from NCCN on Most Common Type of Cancer; Diagnosed in Millions Every Year

New NCCN Guidelines for Patients: Basal Cell Skin Cancer empowers patients and caregivers with knowledge about this widespread, preventable, and easily-cured cancer plus the rare subset that requires more aggressive treatment. PLYMOUTH MEETING, Pa., Oct. 13, 2021 /PRNewswire/ -- The National Com...

2021-10-13 22:07 1970

New Information from NCCN on Most Common Type of Cancer; Diagnosed in Millions Every Year

One-shot Sputnik Light vaccine (first component of the Sputnik V vaccine) demonstrates 70% efficacy against infection with the Delta variant during the first three months after vaccination, Gamaleya Center analysis shows

* The vaccine is more than 75% effective among subjects under the age of 60. Sputnik Light also provides much higher efficacy against severe disease and hospitalizations. * Sputnik Light has demonstrated a superior efficacy compared with some two-shot vaccines, which have shown a major decli...

2021-10-13 20:30 4825

Gannex Announces Clinical and Preclinical Data of Four NASH Programs to be Presented in Oral or Poster Presentation at The Liver Meeting® 2021 by American Association for the Study of Liver Diseases

SHANGHAI, Oct. 13, 2021 /PRNewswire/ -- Gannex Pharma Co., Ltd., a wholly owned company of Ascletis Pharma Inc. (HKEX:1672), announces today that the latest clinical and preclinical data of four NASH programs (ASC40/TVB-2640 co-authored with Sagimet Biosciences Inc., ASC41, ASC42 and ASC43F) will...

2021-10-13 20:30 2328

Berry Oncology Releases Latest Research Results on Early Screening for Multiple Cancers

SHANGHAI, Oct. 13, 2021 /PRNewswire/ -- Berry Oncology, a Chinese oncology genomic testing company, was invited to the inaugural International Biopharma Industry Week inShanghai (IBIWS) running from October 11-14, where CEO Jun Zhou delivered a much-anticipated keynote speech at the "2021 Future ...

2021-10-13 20:20 3114

Berry Oncology Releases Latest Research Results on Early Screening for Multiple Cancers

World Thrombosis Day Campaign Unites Thousands of Global Partners to Shine a Spotlight on Blood Clots as an Urgent Health Problem

In its Eighth Year, the Global Campaign Aims to Increase Public Awareness of Blood Clots that Result from Hospitalization and COVID-19 CHAPEL HILL, N.C., Oct. 13, 2021 /PRNewswire/ -- Today, the World Thrombosis Day campaign encourages the public, healthcare professionals and policy makers to ke...

2021-10-13 14:19 1860

World Thrombosis Day Campaign Unites Thousands of Global Partners to Shine a Spotlight on Blood Clots as an Urgent Health Problem

Gilead Sciences Partners with the International AIDS Society to Champion Stigma-free HIV Care Services in Asia and Latin America

SINGAPORE, Oct. 13, 2021 /PRNewswire/ -- Gilead Sciences, Inc. today announced its partnership with IAS - the International AIDS Society - to expand theMe & My Healthcare Provider campaign to three loca...

2021-10-13 13:00 1546

1 ... 202 203 204205206 207 208 ... 383